Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human phase 1 study in healthy volunteers and participants with Parkinson's disease with and without GBA1 mutations
NL-OMON60777Phase 1Completed
- Sponsor
- Vanqua Bio
- Start
- Jan 2024
- Countries
- 1
01
Overview
Phase 1 trial in Parkinson's disease (PD) (3 arms), sponsored by Vanqua Bio. Primary endpoint: Primary endpoint(s). Started Jan 2024; status: completed.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON60777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60777.